Literature DB >> 11939525

Speciation analysis of trace elements in the brains of individuals with Alzheimer's disease with special emphasis on metallothioneins.

Andrea-Nicole Richarz1, Peter Brätter.   

Abstract

A speciation analysis of protein-bound elements in the cytosol of human brain was achieved by size exclusion chromatographical separation of the biomolecules and on-line detection of the metal profiles in the eluate by hyphenated inductively coupled plasma-mass spectrometry. Post-mortem samples from Alzheimer's disease brains and from brains of a control group were investigated to elucidate changes in the trace element distribution during the pathological process. Special attention was paid to the metallothioneins (MT) - cysteine-rich, metal-binding proteins of low molecular weight, existing in several isoforms. The isoform MT-3 is found especially in the brain and has a growth inhibition function on neurons. The MT peaks were identified in the element profiles. For this purpose, the metal binding capability and the heat stability of MT were taken into consideration. For verification, a comparison with pure MT-3 was carried out and further biochemical and analytical methods were applied to the fractions of the chromatographical run. A comparison between Alzheimer's disease and control brains showed a significant difference concerning the MT-1/-2 and MT-3 metal levels, leading to the assumption that there were oxidative processes having taken place in the Alzheimer's brain samples.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11939525     DOI: 10.1007/s00216-001-1187-5

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  8 in total

Review 1.  Chemistry and biology of mammalian metallothioneins.

Authors:  Milan Vašák; Gabriele Meloni
Journal:  J Biol Inorg Chem       Date:  2011-06-07       Impact factor: 3.358

Review 2.  Metallothionein biology in the ageing and neurodegenerative brain.

Authors:  J Dittmann; S J Fung; J C Vickers; M I Chuah; R S Chung; A K West
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

3.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

4.  The native copper- and zinc-binding protein metallothionein blocks copper-mediated Abeta aggregation and toxicity in rat cortical neurons.

Authors:  Roger S Chung; Claire Howells; Emma D Eaton; Lana Shabala; Kairit Zovo; Peep Palumaa; Rannar Sillard; Adele Woodhouse; William R Bennett; Shannon Ray; James C Vickers; Adrian K West
Journal:  PLoS One       Date:  2010-08-11       Impact factor: 3.240

5.  Standards for Quantitative Metalloproteomic Analysis Using Size Exclusion ICP-MS.

Authors:  Amber Lothian; Blaine R Roberts
Journal:  J Vis Exp       Date:  2016-04-13       Impact factor: 1.355

Review 6.  The Function of Transthyretin Complexes with Metallothionein in Alzheimer's Disease.

Authors:  Natalia Zaręba; Marta Kepinska
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

Review 7.  The position of geochemical variables as causal co-factors of diseases of unknown aetiology.

Authors:  Theophilus C Davies
Journal:  SN Appl Sci       Date:  2022-07-27

8.  Decreased copper in Alzheimer's disease brain is predominantly in the soluble extractable fraction.

Authors:  Alan Rembach; Dominic J Hare; Monica Lind; Christopher J Fowler; Robert A Cherny; Catriona McLean; Ashley I Bush; Colin L Masters; Blaine R Roberts
Journal:  Int J Alzheimers Dis       Date:  2013-10-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.